Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Einstein-DVT Dose-finding Study
NCT00395772Phase 2Completed
- Sponsor
- Bayer
- Start
- Dec 2004
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 2 trial of rivaroxaban in deep vein thrombosis (DVT), sponsored by Bayer. Started Dec 2004; status: completed.
02
Drugs
rivaroxaban
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT00395772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00395772.